Cancer is a huge money maker for Big Pharma, so they'll never get behind any drug that can't be patented. The National Institutes of Health, a government agency, should get behind anything that's even remotely plausible as a cancer cure, but the government is too busy giving money to welfare weenies and queenies, so there's no money there to fund cancer research into unprofitable drugs.The NIH claims it's "the nation’s medical research agency supporting scientific studies that turn discovery into health" but the link you posted has been around since May 2012 and no one has heard anything about this so called cure for cancer.What needs to happen is a bunch of human guinea pits need to come forward and volunteer to be in a control group, but even the most elementary research is still expensive.Cancer is here to stay in capitalistic America, I'm afraid. More people work in Cancer, Inc. than there are Americans who actually have cancer.In fact, some analysts consider that the cancer industry is sustained by a policy of deliberately facing in the wrong direction. For instance, in the late 1970s, after studying the policies, activities, and assets of the major U.S. cancer institutions, the investigative reporters Robert Houston and Gary Null concluded that these institutions had become self-perpetuating organisations whose survival depended on the state of no cure. They wrote, "a solution to cancer would mean the termination of research programs, the obsolescence of skills, the end of dreams of personal glory, triumph over cancer would dry up contributions to self-perpetuating charities and cut off funding from Congress, it would mortally threaten the present clinical establishments by rendering obsolete the expensive surgical, radiological and chemotherapeutic treatments in which so much money, training and equipment is invested.http://rense.com/general9/cre.htm
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ra